P/E at 62.22 vs Industry's 60.25: What the Data Shows for Apollo Hospitals Enterprise Ltd.

2 hours ago
share
Share Via
A price-to-earnings ratio of 62.22 against an industry average of 60.25 represents a modest premium for Apollo Hospitals Enterprise Ltd.. Previously rated Hold by MarketsMojo, the company’s rating was reassessed on 11 May 2026. While the one-year return of 19.57% comfortably outpaces the Sensex’s decline of 6.41%, shorter-term performance reveals a more nuanced picture, with a slight weekly dip contrasting with stronger quarterly gains. The data presents a complex valuation-performance dynamic that merits closer examination.

Valuation Picture: Premium Reflecting Sector Leadership?

The current P/E of Apollo Hospitals Enterprise Ltd. stands at 62.22, slightly above the hospital industry average of 60.25. This premium, while not extreme, suggests that the market is pricing in expectations of sustained earnings growth or superior operational performance relative to peers. Given the company’s large-cap status with a market capitalisation of ₹1,22,004.16 crores, this valuation premium is consistent with its dominant position in the sector. However, the question remains whether this premium is justified by recent performance trends — previously rated Hold, what is Apollo Hospitals’ current rating? The four-parameter analysis factors in the valuation premium alongside other metrics.

Performance Across Timeframes: A Tale of Contrasts

Examining returns over multiple periods reveals a mixed momentum profile. Over the past year, Apollo Hospitals has delivered a robust 19.57% gain, significantly outperforming the Sensex’s 6.41% loss. This outperformance extends to longer horizons as well, with three-year returns at 63.24% versus the Sensex’s 20.78%, and an impressive ten-year return of 547.75% compared to 188.61% for the benchmark. Such figures underscore the company’s sustained growth trajectory over the medium to long term.

Yet, the short-term data paints a more nuanced picture. The stock’s one-week performance shows a slight decline of 0.47%, underperforming the Sensex’s 3.57% gain. Conversely, the three-month return of 13.24% outpaces the Sensex’s 1.39%, indicating a recent recovery after a brief setback. Year-to-date, the stock has gained 20.48%, contrasting with the Sensex’s 10.17% decline. This divergence between short-term weakness and medium-term strength — is this a genuine recovery or a relief rally that will fade at the 50 DMA? — highlights the importance of timeframe in assessing momentum.

Moving Average Configuration: Bullish Across All Horizons

The technical picture for Apollo Hospitals is notably positive, with the stock trading above all key moving averages: 5-day, 20-day, 50-day, 100-day, and 200-day. This comprehensive positioning suggests a strong upward trend across both short and long-term horizons. Such a configuration typically signals sustained buying interest and momentum, reinforcing the stock’s recent price strength. The fact that the stock is just 1.48% away from its 52-week high of ₹8,624.2 further supports this bullish technical stance.

From struggle to strength! This Small Cap from Textile - Machinery is showing early turnaround signals that look promising. Position yourself now for explosive growth potential ahead!

  • - Early turnaround signals
  • - Explosive growth potential
  • - Textile - Machinery recovery play

Position for Explosive Growth →

Sector Performance Context: Hospital Industry Trends

The hospital sector has experienced a mixed performance recently, with a blend of positive, flat, and negative results across constituent stocks. Apollo Hospitals stands out as a sector leader, outperforming many peers on both absolute and relative bases. Its ability to maintain a premium valuation amidst sector volatility indicates investor confidence in its operational resilience and growth prospects. However, the sector’s overall mixed results caution against complacency — should investors in Apollo Hospitals hold, buy more, or reconsider?

Rating Reassessment: From Hold to a New Evaluation

On 11 May 2026, the rating for Apollo Hospitals Enterprise Ltd. was updated from a previous Hold rating assigned by MarketsMOJO. While the current rating is not disclosed, the reassessment reflects a comprehensive review of valuation, performance, technicals, and sector dynamics. This change underscores the evolving nature of the company’s investment profile and the importance of continuous data analysis in understanding its market position.

Want to dive deeper on Apollo Hospitals Enterprise Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!

  • - Real-time research report
  • - Complete fundamental analysis
  • - Peer comparison included

Read the Full Verdict →

Collective Insights: What the Data Shows

Bringing together valuation, performance, technical, and sector data, Apollo Hospitals Enterprise Ltd. presents a compelling profile of a large-cap hospital stock trading at a slight premium to its industry peers. Its strong one-year and longer-term returns contrast with short-term fluctuations, while the bullish moving average configuration supports a positive technical outlook. The sector’s mixed results add context to the company’s relative strength, and the recent rating reassessment signals a fresh evaluation of its investment merits. Taken together, these data points offer a nuanced view of the stock’s current standing — what is the current rating for Apollo Hospitals Enterprise Ltd.?

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News